10-K
Annual Report
AGENUS INC
AGEN
NASDAQ
CIK: 1098972
File #: 000-29089
Balance Sheet
52 line items · 2 periods
XBRL
| Item | Dec 31, 2024 | Dec 31, 2023 |
|---|---|---|
ASSETS | ||
Cash and cash equivalents | 40,437,000 | 76,110,000 |
Institutional Money Market Funds - Estimated Fair Value | 6,954,000 | 70,485,000 |
Institutional Money Market Funds - Cost | 6,954,000 | 70,485,000 |
Estimated Fair Value | 6,954,000 | 70,485,000 |
Cost | 6,954,000 | 70,485,000 |
Accounts receivable | 407,000 | 25,836,000 |
Prepaid expenses | 2,315,000 | 8,098,000 |
Other current assets | 2,415,000 | 2,372,000 |
Total current assets | 45,574,000 | 112,416,000 |
Property, plant and equipment, net of accumulated amortization and depreciation of $72,553 and $61,943 at December 31, 2024 and 2023, respectively | 120,087,000 | 133,421,000 |
Operating lease right-of-use assets | 27,308,000 | 29,606,000 |
Goodwill | 24,092,000 | 24,723,000 |
Acquired intangible assets, net of accumulated amortization of $16,986 and $17,688 at December 31, 2024 and 2023, respectively | 3,376,000 | 4,411,000 |
Other long-term assets | 5,834,000 | 9,336,000 |
Total assets | 226,271,000 | 313,913,000 |
LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' DEFICIT | ||
Current portion, long-term debt | 2,698,000 | 146,000 |
Debentures | 146,000 | — |
2015 Subordinated Notes | 2,471,000 | — |
Other services | 81,000 | — |
Current portion, liability related to sale of future royalties and milestones | 111,978,000 | 132,502,000 |
Current portion, deferred revenue | 31,000 | 18,000 |
Current portion, operating lease liabilities | 2,446,000 | 2,587,000 |
Accounts payable | 61,470,000 | 61,446,000 |
Accrued liabilities | 34,961,000 | 45,283,000 |
Other current liabilities | 7,817,000 | 13,915,000 |
Total current liabilities | 221,401,000 | 255,897,000 |
Long-term debt, net of current portion | 30,473,000 | 12,768,000 |
2015 Subordinated Notes | 10,500,000 | — |
Promissory Note | 19,973,000 | — |
Liability related to sale of future royalties and milestones, net of current portion | 224,389,000 | 124,556,000 |
Deferred revenue, net of current portion | 1,143,000 | 1,143,000 |
Operating lease liabilities, net of current portion | 54,551,000 | 62,511,000 |
Other long-term liabilities | 738,000 | 5,420,000 |
STOCKHOLDERS' DEFICIT | ||
Series A-1 convertible preferred stock | 0 | 0 |
Common stock, par value $0.01 per share; 800,000,000 shares authorized at December 31, 2024 and 2023; 23,634,670 shares and 19,718,662 shares issued at December 31, 2024 and 2023, respectively | 236,000 | 197,000 |
Additional paid-in capital | 1,857,662,000 | 1,796,095,000 |
Accumulated other comprehensive loss | (1,398,000) | (955,000) |
Accumulated deficit | (2,182,880,000) | (1,955,668,000) |
Total stockholders' deficit attributable to Agenus Inc. | (326,380,000) | (160,331,000) |
Non-controlling interest | 19,956,000 | 11,949,000 |
Non-controlling Interest | 19,956,000 | 11,949,000 |
Total stockholders' deficit | (306,424,000) | (148,382,000) |
Accumulated Deficit | (2,182,880,000) | (1,955,668,000) |
Additional Paid-in Capital | 1,857,662,000 | 1,796,095,000 |
Common Stock | 236,000 | 197,000 |
Non-controlling Interest | 19,956,000 | 11,949,000 |
Series A-1 convertible preferred stock - Preferred Stock | 0 | 0 |
Accumulated Other Comprehensive Income (Loss) | (1,398,000) | (955,000) |
Total liabilities, convertible preferred stock and stockholders' deficit | 226,271,000 | 313,913,000 |